HERV-K(HML-2), the Best Preserved Family of HERVs: Endogenization, Expression, and Implications in Health and Disease.

Oliver Hohn, Kirsten Hanke, Norbert Bannert
Author Information
  1. Oliver Hohn: Division for HIV and Other Retroviruses, Robert Koch Institute , Berlin , Germany.

Abstract

Retroviruses that have the ability to infect germ line cells can become an integral and inherited part of the host genome. About 8% of the human chromosomal DNA consists of sequences derived from infections by retroviruses that presumably circulated 2-40 millions of years ago, and some elements are actually much older. Post-insertional recombinations, deletions, and mutations have rendered all known human endogenous retroviruses (HERVs) non-infectious. However some, particularly the most recently acquired proviruses of the HERV-K(HML-2) family, can expresses viral proteins and produce viral particles. In this review we will first discuss the major aspects of the endogenization process and peculiarities of the different HERV-K families. We will then focus on the genes and proteins encoded by HERV-K(HML-2) as well as inactivation of these proviruses by postinsertional mutations and their inhibition by antiretroviral factors. After describing the evolutionary interplay between host and endogenous retrovirus we will delve deeper into the currently limited understanding of HERV-K and its possible association with disease, particularly tumorigenesis.

Keywords

References

  1. PLoS Pathog. 2007 Jan;3(1):e10 [PMID: 17257061]
  2. J Gen Virol. 1999 Apr;80 ( Pt 4):841-845 [PMID: 10211951]
  3. Melanoma Res. 2010 Oct;20(5):435-40 [PMID: 20539243]
  4. Genome Res. 2006 Dec;16(12):1548-56 [PMID: 17077319]
  5. J Virol. 1987 Jun;61(6):2059-62 [PMID: 2883329]
  6. J Virol Methods. 2006 Sep;136(1-2):51-7 [PMID: 16678919]
  7. J Virol. 2005 Oct;79(19):12507-14 [PMID: 16160178]
  8. J Gen Virol. 2004 Jan;85(Pt 1):1-13 [PMID: 14718613]
  9. Nat Genet. 2004 Jun;36(6):653-9 [PMID: 15156143]
  10. J Reprod Immunol. 2011 Sep;91(1-2):1-8 [PMID: 21840605]
  11. Bioinformatics. 2008 Jul 15;24(14):1563-7 [PMID: 18535086]
  12. Nat Med. 2010 May;16(5):571-9, 1p following 579 [PMID: 20436485]
  13. J Virol. 2006 Nov;80(21):10752-62 [PMID: 17041225]
  14. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8 [PMID: 10557333]
  15. J Virol. 2003 Jan;77(1):749-53 [PMID: 12477881]
  16. Genomics. 2005 Sep;86(3):337-41 [PMID: 16024218]
  17. Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3782-7 [PMID: 20142478]
  18. Leukemia. 2013 Jul;27(7):1469-78 [PMID: 23307033]
  19. Med J Aust. 2009 Nov 2;191(9):478-9 [PMID: 19883339]
  20. J Virol. 2008 Sep;82(17):8762-70 [PMID: 18562521]
  21. Genome Res. 2004 Nov;14(11):2253-60 [PMID: 15520289]
  22. PLoS Pathog. 2007 Nov;3(11):e170 [PMID: 17997604]
  23. J Virol. 1986 Nov;60(2):589-98 [PMID: 3021993]
  24. Virology. 2002 Jun 5;297(2):220-5 [PMID: 12083821]
  25. Mol Biol Evol. 2004 Oct;21(10):1895-901 [PMID: 15254254]
  26. J Gen Virol. 1999 Jan;80 ( Pt 1):255-260 [PMID: 9934709]
  27. Nat Med. 1997 Mar;3(3):282-6 [PMID: 9055854]
  28. Mol Cancer. 2004 Apr 26;3:12 [PMID: 15109395]
  29. Biochim Biophys Acta. 2011 Feb;1812(2):162-76 [PMID: 20696240]
  30. Nucleic Acids Res. 1994 Dec 11;22(24):5211-7 [PMID: 7816608]
  31. Science. 1975 Apr 11;188(4184):107-16 [PMID: 1090005]
  32. Placenta. 2012 Sep;33(9):663-71 [PMID: 22695103]
  33. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10254-60 [PMID: 10468595]
  34. Virus Res. 2007 Feb;123(2):211-5 [PMID: 17005285]
  35. J Virol. 1996 Jan;70(1):188-98 [PMID: 8523525]
  36. J Mol Evol. 2004 Nov;59(5):642-56 [PMID: 15693620]
  37. Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):725-30 [PMID: 15644441]
  38. Nature. 2000 Feb 17;403(6771):785-9 [PMID: 10693809]
  39. J Virol. 2005 Jan;79(2):876-83 [PMID: 15613316]
  40. J Virol. 1998 Oct;72(10):8384-91 [PMID: 9733890]
  41. J Gen Virol. 1984 May;65 ( Pt 5):887-98 [PMID: 6202829]
  42. J Virol. 2005 Mar;79(5):2941-9 [PMID: 15709013]
  43. Virology. 1971 Aug;45(2):508-15 [PMID: 4328812]
  44. World J Gastroenterol. 2012 Nov 14;18(42):6027-35 [PMID: 23155332]
  45. Int J Cancer. 2010 Jan 15;126(2):306-14 [PMID: 19795446]
  46. Neoplasia. 2008 Jun;10(6):521-33 [PMID: 18516289]
  47. Int MS J. 2003 Apr;10(1):22-8 [PMID: 12906767]
  48. Genes Dev. 1992 Aug;6(8):1457-65 [PMID: 1379564]
  49. J Androl. 2001 Nov-Dec;22(6):999-1011 [PMID: 11700865]
  50. Nature. 2012 Nov 29;491(7426):774-8 [PMID: 23103862]
  51. J Virol. 1999 Nov;73(11):9496-507 [PMID: 10516058]
  52. Cancer Res. 2005 May 15;65(10):4172-80 [PMID: 15899808]
  53. Leukemia. 2002 Feb;16(2):254-9 [PMID: 11840292]
  54. J Virol. 2004 Oct;78(19):10310-9 [PMID: 15367597]
  55. AIDS Res Hum Retroviruses. 2008 Mar;24(3):363-5 [PMID: 18327982]
  56. J Gen Virol. 2010 Jun;91(Pt 6):1494-502 [PMID: 20147518]
  57. J Mammary Gland Biol Neoplasia. 2001 Jan;6(1):23-36 [PMID: 11467450]
  58. Retrovirology. 2006 Oct 03;3:67 [PMID: 17018135]
  59. Nat Genet. 2004 Jun;36(6):647-52 [PMID: 15156142]
  60. J Virol. 2008 Oct;82(19):9329-36 [PMID: 18632860]
  61. Br J Cancer. 1999 Jul;80(9):1312-21 [PMID: 10424731]
  62. Oncogene. 2005 Apr 28;24(19):3223-8 [PMID: 15735668]
  63. Retrovirology. 2005 Aug 10;2:50 [PMID: 16092962]
  64. Science. 2011 Jul 1;333(6038):97-101 [PMID: 21628392]
  65. Annu Rev Genomics Hum Genet. 2006;7:149-73 [PMID: 16722807]
  66. AIDS Res Hum Retroviruses. 2006 Oct;22(10):979-84 [PMID: 17067267]
  67. Melanoma Res. 1992 Sep;2(3):207-11 [PMID: 1450674]
  68. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12127-32 [PMID: 19564597]
  69. Exp Cell Res. 2009 Mar 10;315(5):849-62 [PMID: 19167380]
  70. Br J Dermatol. 2009 Dec;161(6):1225-31 [PMID: 19785608]
  71. Oncogene. 2000 Sep 7;19(38):4328-36 [PMID: 10980608]
  72. J Virol. 1999 Feb;73(2):1254-61 [PMID: 9882329]
  73. Int J Cancer. 2007 Jan 1;120(1):81-90 [PMID: 17013901]
  74. Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 1):293-6 [PMID: 10207631]
  75. Cytogenet Genome Res. 2005;110(1-4):448-56 [PMID: 16093697]
  76. BMC Bioinformatics. 2007 May 03;8 Suppl 2:S11 [PMID: 17493249]
  77. Virology. 1971 Jan;43(1):223-34 [PMID: 5101017]
  78. Retrovirology. 2012 Jan 16;9:6 [PMID: 22248111]
  79. Virology. 2008 Feb 5;371(1):216-25 [PMID: 18076964]
  80. Trends Genet. 2008 Feb;24(2):53-6 [PMID: 18192066]
  81. Cancer Res. 2005 Apr 1;65(7):2588-91 [PMID: 15805254]
  82. J Virol. 2007 Jun;81(11):5607-16 [PMID: 17360752]
  83. Mol Cells. 2003 Feb 28;15(1):75-80 [PMID: 12661764]
  84. Oncogene. 2007 Jun 21;26(29):4226-33 [PMID: 17237820]
  85. Cell. 1997 Jul 25;90(2):303-13 [PMID: 9244304]
  86. J Virol. 1986 Jun;58(3):937-44 [PMID: 3009897]
  87. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13013-8 [PMID: 14557543]
  88. J Virol. 2005 Dec;79(24):15573-7 [PMID: 16306628]
  89. J Virol. 1995 Jan;69(1):141-9 [PMID: 7983704]
  90. J Clin Invest. 2012 Dec;122(12):4473-89 [PMID: 23143309]
  91. Oncogene. 2003 Mar 13;22(10):1528-35 [PMID: 12629516]
  92. AIDS Res Hum Retroviruses. 2008 May;24(5):717-23 [PMID: 18462078]
  93. Nature. 2006 Jul 6;442(7098):79-81 [PMID: 16823453]
  94. Gene. 2009 Dec 15;448(2):105-14 [PMID: 19577618]
  95. J Rheumatol. 2005 Sep;32(9):1821-31 [PMID: 16142883]
  96. Int J Cancer. 2004 Jun 20;110(3):459-61 [PMID: 15095315]
  97. J Virol. 2011 Jul;85(14):6977-85 [PMID: 21525339]
  98. Cancer Cell. 2003 Jun;3(6):551-64 [PMID: 12842084]
  99. J Virol. 2012 Aug;86(15):7790-805 [PMID: 22593154]
  100. Pigment Cell Melanoma Res. 2011 Aug;24(4):656-65 [PMID: 21501418]
  101. Retrovirology. 2011 Nov 08;8:90 [PMID: 22067224]
  102. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12841-6 [PMID: 14534330]
  103. Int J Gynecol Cancer. 2011 Jan;21(1):51-7 [PMID: 21330831]
  104. Semin Cancer Biol. 2010 Aug;20(4):246-53 [PMID: 20685251]
  105. Virology. 1999 Mar 30;256(1):22-35 [PMID: 10087223]
  106. Eur J Cancer. 2005 Jan;41(1):104-17 [PMID: 15617995]
  107. J Gen Virol. 2008 Feb;89(Pt 2):567-572 [PMID: 18198388]
  108. J Gen Virol. 1996 Dec;77 ( Pt 12):2983-90 [PMID: 9000088]
  109. Nature. 2007 Aug 2;448(7153):595-9 [PMID: 17671502]
  110. Cancer Res. 2008 Jul 15;68(14):5869-77 [PMID: 18632641]
  111. BMC Cancer. 2013 Jan 03;13:4 [PMID: 23282240]
  112. J Virol. 2012 Jan;86(1):262-76 [PMID: 22031938]
  113. Proc Natl Acad Sci U S A. 1970 Sep;67(1):377-84 [PMID: 4318784]
  114. Clin Cancer Res. 2002 Jun;8(6):1800-7 [PMID: 12060620]
  115. Int J Androl. 2006 Feb;29(1):219-27 [PMID: 16466543]
  116. Arch Virol. 2005 Jan;150(1):177-84 [PMID: 15449135]
  117. Melanoma Res. 2006 Jun;16(3):223-34 [PMID: 16718269]
  118. J Virol. 2013 May;87(9):5081-8 [PMID: 23427161]
  119. Diabetes. 2004 Mar;53(3):852-4 [PMID: 14988274]
  120. Cell Mol Life Sci. 2008 Nov;65(21):3366-82 [PMID: 18818873]
  121. Retrovirology. 2011 May 09;8:30 [PMID: 21554716]
  122. Mult Scler. 2008 Nov;14(9):1175-80 [PMID: 18701576]
  123. PLoS Pathog. 2007 Nov;3(11):e165 [PMID: 17997601]
  124. J Virol. 1995 Jan;69(1):414-21 [PMID: 7983737]
  125. Nature. 1996 Aug 29;382(6594):826-9 [PMID: 8752279]
  126. Virology. 1987 Mar;157(1):236-40 [PMID: 3029962]
  127. Cancer Res. 2007 Oct 15;67(20):10087-96 [PMID: 17942943]
  128. Cancer Res. 2003 Dec 15;63(24):8735-41 [PMID: 14695188]
  129. Genomics. 2002 Sep;80(3):331-43 [PMID: 12213204]
  130. J Virol. 1988 Apr;62(4):1203-10 [PMID: 2831381]
  131. Tumour Biol. 2004 May-Jun;25(3):99-105 [PMID: 15361705]
  132. Curr Biol. 2001 Oct 2;11(19):1531-5 [PMID: 11591322]
  133. J Mol Evol. 2003 Dec;57(6):642-9 [PMID: 14745533]
  134. Am J Pathol. 1996 Nov;149(5):1727-35 [PMID: 8909261]
  135. PLoS One. 2012;7(6):e40194 [PMID: 22761958]
  136. Genome Biol Evol. 2013;5(2):307-28 [PMID: 23338945]
  137. Retrovirology. 2013 Feb 09;10:16 [PMID: 23394165]
  138. J Virol. 2009 Dec;83(24):12790-800 [PMID: 19812154]
  139. J Negat Results Biomed. 2013 Jan 10;12:3 [PMID: 23305161]
  140. Int J Cancer. 2013 Feb 1;132(3):556-67 [PMID: 22733359]
  141. Clin Exp Immunol. 2010 Jun;160(3):340-7 [PMID: 20345981]
  142. Cancer Res. 2002 Oct 1;62(19):5510-6 [PMID: 12359761]
  143. J Virol. 2009 Jun;83(12):6098-105 [PMID: 19339349]
  144. J Gen Virol. 1997 Jul;78 ( Pt 7):1731-44 [PMID: 9225050]
  145. Virology. 1993 Sep;196(1):349-53 [PMID: 8356806]
  146. Cancer Immun. 2008 Nov 13;8:15 [PMID: 19006261]
  147. J Virol. 1993 Nov;67(11):6778-87 [PMID: 7692084]
  148. J Virol. 2006 Jun;80(11):5651-4 [PMID: 16699047]
  149. Semin Neurol. 2011 Jul;31(3):307-16 [PMID: 21964847]

Word Cloud

Created with Highcharts 10.0.0HERV-KhumanendogenousHML-2willcanhostretrovirusesmutationsparticularlyprovirusesviralproteinsretrovirusRetrovirusesabilityinfectgermlinecellsbecomeintegralinheritedpartgenome8%chromosomalDNAconsistssequencesderivedinfectionspresumablycirculated2-40millionsyearsagoelementsactuallymucholderPost-insertionalrecombinationsdeletionsrenderedknownHERVsnon-infectiousHoweverrecentlyacquiredfamilyexpressesproduceparticlesreviewfirstdiscussmajoraspectsendogenizationprocesspeculiaritiesdifferentfamiliesfocusgenesencodedwellinactivationpostinsertionalinhibitionantiretroviralfactorsdescribingevolutionaryinterplaydelvedeepercurrentlylimitedunderstandingpossibleassociationdiseasetumorigenesisBestPreservedFamilyHERVs:EndogenizationExpressionImplicationsHealthDiseaseReccancerreplication

Similar Articles

Cited By